1. Monash Health
  2. Monash Health research
  3. Articles
Please use this identifier to cite or link to this item: https://repository.monashhealth.org/monashhealthjspui/handle/1/28976
Full metadata record
DC FieldValueLanguage
dc.contributor.authorNgo D.en
dc.contributor.authorMcLean C.A.en
dc.contributor.authorStock M.en
dc.contributor.authorKlassert T.E.en
dc.contributor.authorSlevogt H.en
dc.contributor.authorMangan N.E.en
dc.contributor.authorCheng W.en
dc.contributor.authorFischer D.en
dc.contributor.authorGfroerer S.en
dc.contributor.authorSandhu M.K.en
dc.contributor.authorBui C.B.en
dc.contributor.authorBujotzek A.en
dc.contributor.authorLariviere L.en
dc.contributor.authorSchumacher F.en
dc.contributor.authorTiefenthaler G.en
dc.contributor.authorBeker F.en
dc.contributor.authorCollins C.en
dc.contributor.authorKamlin C.O.F.en
dc.contributor.authorKonig K.en
dc.contributor.authorMalhotra A.en
dc.contributor.authorTheda C.en
dc.contributor.authorVeldman A.en
dc.contributor.authorEllisdon A.M.en
dc.contributor.authorWhisstock J.C.en
dc.contributor.authorBerger P.J.en
dc.contributor.authorNold M.F.en
dc.contributor.authorNold-Petry C.A.en
dc.contributor.authorTan K.en
dc.contributor.authorCho S.X.en
dc.contributor.authorRudloff I.en
dc.contributor.authorLao J.C.en
dc.contributor.authorPang M.A.en
dc.contributor.authorGoldberg R.en
dc.date.accessioned2021-05-14T09:46:16Zen
dc.date.available2021-05-14T09:46:16Zen
dc.date.copyright2020en
dc.date.created20201224en
dc.date.issued2020-12-24en
dc.identifier.citationNature Communications. 11 (1) (no pagination), 2020. Article Number: 5794. Date of Publication: December 2020.en
dc.identifier.issn2041-1723 (electronic)en
dc.identifier.urihttps://repository.monashhealth.org/monashhealthjspui/handle/1/28976en
dc.description.abstractNecrotizing enterocolitis (NEC) is a severe, currently untreatable intestinal disease that predominantly affects preterm infants and is driven by poorly characterized inflammatory pathways. Here, human and murine NEC intestines exhibit an unexpected predominance of type 3/TH17 polarization. In murine NEC, pro-inflammatory type 3 NKp46-RORgammat+Tbet+ innate lymphoid cells (ILC3) are 5-fold increased, whereas ILC1 and protective NKp46+RORgammat+ ILC3 are obliterated. Both species exhibit dysregulation of intestinal TLR repertoires, with TLR4 and TLR8 increased, but TLR5-7 and TLR9-12 reduced. Transgenic IL-37 effectively protects mice from intestinal injury and mortality, whilst exogenous IL-37 is only modestly efficacious. Mechanistically, IL-37 favorably modulates immune homeostasis, TLR repertoires and microbial diversity. Moreover, IL-37 and its receptor IL-1R8 are reduced in human NEC epithelia, and IL-37 is lower in blood monocytes from infants with NEC and/or lower birthweight. Our results on NEC pathomechanisms thus implicate type 3 cytokines, TLRs and IL-37 as potential targets for novel NEC therapies.Copyright © 2020, The Author(s).en
dc.languageenen
dc.languageEnglishen
dc.publisherNature Researchen
dc.relation.ispartofNature Communicationsen
dc.titleCharacterization of the pathoimmunology of necrotizing enterocolitis reveals novel therapeutic opportunities.en
dc.typeArticleen
dc.identifier.doihttp://monash.idm.oclc.org/login?url=http://dx.doi.org/10.1038/s41467-020-19400-w-
dc.publisher.placeUnited Kingdomen
dc.identifier.pubmedid33188181 [http://www.ncbi.nlm.nih.gov/pubmed/?term=33188181]en
dc.identifier.source2007294976en
dc.identifier.institution(Cho, Rudloff, Lao, Pang, Goldberg, Bui, Sandhu, Ngo, Malhotra, Tan, Berger, Nold-Petry, Nold) Department of Paediatrics, Monash University, Melbourne, VIC, Australia (Cho, Rudloff, Lao, Pang, Goldberg, Bui, Sandhu, Ngo, Malhotra, Tan, Veldman, Berger, Nold-Petry, Nold) Ritchie Centre, Hudson Institute of Medical Research, Melbourne, VIC, Australia (Cho) Department of Immunology, Hokkaido University Graduate School of Medicine, Sapporo, Japan (Goldberg) Department of Medicine, Monash University, Melbourne, VIC, Australia (Goldberg, Sandhu) Department of Gastroenterology, Monash Health, Melbourne, VIC, Australia (McLean) Department of Anatomical Pathology, Alfred Hospital, Melbourne, VIC, Australia (McLean) Central Clinical School, Monash University, Melbourne, VIC, Australia (Stock, Klassert, Slevogt) ZIK Septomics, Jena University Hospital, Jena, Germany (Mangan) Department of Molecular and Translational Science, Monash University, Melbourne, VIC, Australia (Mangan) Centre for Innate Immunity and Infectious Diseases, Hudson Institute of Medical Research, Melbourne, VIC, Australia (Cheng) Department of Surgery, Beijing United Family Hospital, Beijing, China (Cheng) Capital Institute of Pediatrics, Beijing, China (Fischer) Department of Pediatrics, Goethe University Hospital, Frankfurt, Germany (Fischer, Veldman) Department of Pediatrics, St. Vincenz Hospital, Limburg, Germany (Gfroerer) Department of Pediatric Surgery, Goethe University Hospital, Frankfurt, Germany (Gfroerer) Helios Clinic Berlin-Buch, Berlin, Germany (Bujotzek, Lariviere, Schumacher, Tiefenthaler) Roche Pharma Research and Early Development, Roche Innovation Center Munich, Penzberg, Germany (Beker) Mater Research Institute, University of Queensland, Brisbane, QLD, Australia (Beker, Collins) Neonatal Services, Mercy Hospital for Women, Melbourne, VIC, Australia (Collins) Joan Kirner Women's & Children's, Sunshine Hospital, Melbourne, VIC, Australia (Kamlin, Theda) Department of Newborn Research, Royal Women's Hospital, Melbourne, VIC, Australia (Kamlin, Theda) University of Melbourne, Melbourne, VIC, Australia (Kamlin, Theda) Murdoch Children's Research Institute, Melbourne, VIC, Australia (Konig) Medicum Wesemlin, Department of Paediatrics, Lucerne, Switzerland (Malhotra, Tan, Nold) Monash Newborn, Monash Children's Hospital, Melbourne, VIC, Australia (Veldman) Department of Pediatrics, Liebig University Hospital, Giessen, Germany (Ellisdon, Whisstock) Biomedicine Discovery Institute and Department of Biochemistry and Molecular Biology, Monash University, Melbourne, VIC, Australia (Whisstock) Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Melbourne, VIC, Australiaen
dc.description.addressM.F. Nold, Department of Paediatrics, Monash University, Melbourne, VIC, Australia. E-mail: marcel.nold@monash.eduen
dc.description.publicationstatusEmbaseen
dc.rights.statementCopyright 2020 Elsevier B.V., All rights reserved.en
dc.identifier.authoremailNold M.F.; marcel.nold@monash.eduen
dc.description.grantNo: 1043845 Organization: (NHMRC) *National Health and Medical Research Council* Organization No: 501100000925 Country: Australiaen
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeArticle-
item.grantfulltextnone-
item.fulltextNo Fulltext-
crisitem.author.deptPaediatric - Neonatal (Monash Newborn)-
crisitem.author.deptPaediatric - Neonatal (Monash Newborn)-
crisitem.author.deptHudson Institute - The Ritchie Centre-
Appears in Collections:Articles
Show simple item record

Page view(s)

28
checked on Sep 7, 2024

Google ScholarTM

Check


Items in Monash Health Research Repository are protected by copyright, with all rights reserved, unless otherwise indicated.